J. Brockm�ller

Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3?-flanking region

Nikolaos Drakoulis, Ingolf Cascorbi, J. Brockm�ller et al. · Journal of Molecular Medicine · 1994 · 117 citations

Medicine, Genetics, Molecular Genetics +11

Pharmacokinetic interaction between cyclosporin and diltiazem

J. Brockm�ller, H.-H. Neumayer, Karl Wagner et al. · European Journal of Clinical Pharmacology · 1990 · 57 citations

Medicine, Pharmacokinetics, Pharmacology +12

Pharmacokinetics of Recombinant Human Erythropoietin after SC Administration and in Long-Term IV Treatment in Patients on Maintenance Hemodialysis

Hans‐H. Neumayer, J. Brockm�ller, Emmanuel Fritschka et al. · Contributions to nephrology · 2015 · 43 citations

Medicine, Pharmacokinetics, Pharmacology +16

Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients

Ivar Roots, J. Brockm�ller, Nikolaos Drakoulis et al. · Journal of Molecular Medicine · 1992 · 29 citations

Medicine, Genetics, Oncology +17

Limited contribution of CYP3A5 to the hepatic 6?-hydroxylation of testosterone

Landry K. Kamdem, Ingolf Meineke, Ina Koch et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2004 · 19 citations

Medicine, Biochemistry, Pharmacokinetics +12